HeartBeam, Inc.

Name: HeartBeam, Inc. standardized financial statements, quarterly
Creator: Listed

BEATWNasdaqCIK 1779372HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$5.1m, Q2 FY2026

Net income−$5.0m, Q2 FY2026

HeartBeam, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Research and development	$k	1,623	2,010	2,428	2,844	2,893	2,886	3,492	3,326	3,278	3,354	2,370	2,328
Selling, general and administrative	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$k	(3,737)	(4,109)	(4,784)	(5,090)	(5,069)	(4,944)	(5,504)	(5,037)	(5,290)	(5,310)	(4,716)	(5,092)
Interest expense	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$k	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$k	(3,470)	(3,879)	(4,606)	(4,956)	(4,979)	(4,907)	(5,484)	(4,974)	(5,255)	(5,302)	(4,700)	(5,039)
Diluted EPS	$ per share	(0.13)	not reported	(0.17)	(0.19)	(0.19)	not reported	(0.18)	(0.15)	(0.15)	not reported	(0.12)	(0.10)
Basic EPS	$ per share	(0.13)	not reported	(0.17)	(0.19)	(0.19)	not reported	(0.18)	(0.15)	(0.15)	not reported	(0.12)	(0.10)

Balance sheet

Cash and equivalents$8.7m, Q2 FY2026

Shareholders' equity$8.2m, Q2 FY2026

HeartBeam, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	19.2	16.2	12.6	9.2	5.8	2.4	4.4	3.3	1.9	4.4	2.0	8.7
Current assets	$m	19.5	16.8	13.2	9.7	6.1	2.8	8.6	5.4	2.1	4.7	2.4	9.0
Total assets	$m	19.6	17.1	13.6	10.1	6.7	3.3	9.1	6.0	2.9	5.8	3.9	10.6
Current liabilities	$m	not reported	1.2	not reported	1.4	1.9	1.6	1.6	1.8	2.5	3.2	3.3	2.5
Total liabilities	$m	1.0	1.2	1.1	1.4	1.9	1.6	1.6	1.8	2.5	3.2	3.3	2.5
Shareholders' equity	$m	18.6	15.9	12.5	8.7	4.8	1.7	7.5	4.2	0.4	2.6	0.6	8.2

Cash flow

Operating cash flow−$3.3m, Q2 FY2026

Capital expenditure$249.0k, Q2 FY2026

HeartBeam, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(2,098)	(2,858)	(3,463)	(3,550)	(3,306)	(4,152)	(4,477)	(3,445)	(3,160)	(2,906)	(3,610)	(3,342)
Capital expenditure	$k	144	112	88.0	10.0	103	0.0	0.0	102	82.0	416	246	249

Diluted shares (weighted)52.77m, Q2 FY2026

HeartBeam, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	8.1	8.2	19.7	26.4	26.5	26.6	26.8	30.4	33.8	34.4	40.6	52.8

Shares outstanding: 56.35m at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.